Treatment of ocular hypertension with beta-blockers and derivatives of prostanoic acid

摘要

An agent for the treatment of ocular hypertension, comprising (a) a beta -adrenergic blocker to be administered at the enhancement phase of aqueous humor production and (b) a prostanoic acid compound to be administered at the suppression phase of aqueous humor production, the component (a) and (b) are contained in separate dosage forms.